Doç. Dr. MELİH TÜTÜNCÜ

Yayın Ağı

Makaleler 79

1. Non-Motor Symptoms in Myasthenia Gravis Patients: Evaluation of Auditory and Olfactory Functions

Akdoğan Ö., Sar A., Eren T., Akdemir E., Boyoğlu N. S., Tütüncü M., et al.

Noropsikiyatri Arsivi , cilt.63, ss.219-225, 2026 (SCI-Expanded, Scopus, TRDizin)

2. Real-world effectiveness and safety of eculizumab in AQP4-IgG-positive neuromyelitis optica spectrum disorder

KOÇ E. R., YETKİN M. F., SARIDAŞ F., Turan O. F., Sevim S., Terzi M., et al.

Journal of Neurology , cilt.273, sa.1, 2026 (SCI-Expanded, Scopus)

3. Microstructural analysis of verbal fluency performance in relapsing-remitting multiple sclerosis based on the impact of disability level

Altun M. B., Öge-Daşdöğen Ö., Tütüncü M.

Applied Neuropsychology:Adult , cilt.33, sa.1, ss.125-135, 2026 (SCI-Expanded, Scopus)

4. Exome sequencing reveals low-frequency and rare variant contributions to multiple sclerosis susceptibility in Turkish families

Büyükgöl F., GÜRDAMAR B., Aluçlu M. U., Beckmann Y., BİLGÜVAR K., BOZ C., et al.

Scientific Reports , cilt.15, sa.1, 2025 (SCI-Expanded, Scopus)

5. 3D T1-Weighted Black-Blood MRI in the Diagnosis and Follow-Up of Facial Neuritis: a Single-Center Prospective Study

Karaman A. K., KORKMAZER B., Öz A., Erener N., MUSAYEV M., SAMANCI C., et al.

Clinical Neuroradiology , cilt.35, sa.4, ss.785-793, 2025 (SCI-Expanded, Scopus)

6. Comparative efficacy of rituximab versus azathioprine in the treatment of MOG antibody-associated disease (MOGAD)

Şen S., KÜRTÜNCÜ M., Demir S., GÜNDÜZ T., Demirel E., TÜTÜNCÜ M., et al.

JOURNAL OF NEUROIMMUNOLOGY , cilt.407, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

7. Unemployment, work hour reduction, and income loss: An international, multicentered, cross-sectional study of neuromyelitis optica spectrum disorder

Ham A. S., Gomez Hjerthen I., Tian D., Gu H., Gao W., Sudhir A., et al.

Multiple Sclerosis Journal , cilt.31, sa.11, ss.1358-1369, 2025 (SCI-Expanded, Scopus)

8. Live Cell-Based Flow Cytometry Assay Versus Commercial Cell-Based Indirect Immunofluorescence Assay of Aquaporin-4 Antibody in Neuromyelitis Optica: A Comparative study

Dogan I. G., Yigit M., Tezer D. C., Gulacti O., Ayhan S., Turkdemir I. D., et al.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.62, sa.3, ss.259-263, 2025 (SCI-Expanded, Scopus, TRDizin)

9. Evaluation of nonmotor symptoms in myasthenia gravis patients

Tekeşin A., Şişman Ç., Toprak U. E., Sar A., Akalin B., Koşargelir G., et al.

Turkish Journal of Medical Sciences , cilt.55, sa.1, ss.127-139, 2025 (SCI-Expanded, Scopus, TRDizin)

10. Early Disease-Modifying Treatments for Presymptomatic Multiple Sclerosis

Zeydan B., Azevedo C. J., Makhani N., Cohen M., TÜTÜNCÜ M., Thouvenot E., et al.

CNS DRUGS , cilt.38, sa.12, ss.973-983, 2024 (SCI-Expanded, Scopus)

11. Employment, work hours, and wages in adults with myelin oligodendrocyte glycoprotein antibody disease: An international cohort study.

Ham A. S., Gomez Hjerthen I., Sudhir A., Pandit L., Reddy Y. M., Murthy J. M., et al.

Multiple sclerosis (Houndmills, Basingstoke, England) , cilt.30, sa.13, ss.1674-1682, 2024 (SCI-Expanded, Scopus)

12. Mimickers of nervous system involvement among patients with Behçet's syndrome

Nas E. D., ÇALIŞKAN E., Gulec Z. E., UYGUNOĞLU U., Tutuncu M., Saip S., et al.

JOURNAL OF NEUROLOGY , cilt.271, sa.10, ss.6903-6911, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

13. Exploring the experience of multiple sclerosis patients in Turkey: Insights from a national survey

TÜTÜNCÜ M., Demir S., Gunduz T., Mavi K., Oelmez C., Igde F., et al.

NEUROLOGY ASIA , cilt.29, sa.3, ss.749-761, 2024 (SCI-Expanded, Scopus)

14. Erdheim-Chester disease of brain parenchyma without any systemic involvement: A case report and review of literature

Aktan Suzgun M., Everest E., Kucukyurt S., Tutuncu M., Uygunoğlu U., Eşkazan A. E., et al.

NEUROPATHOLOGY , cilt.44, sa.1, ss.59-67, 2024 (SCI-Expanded, Scopus)

15. Severe disease reactivation in seropositive neuromyelitis optica spectrum disorders patients after stopping eculizumab treatment

Sen S., Tuncer A., Terzi M., BÜNÜL S. D., Ozen-Acar P., Altunrende B., et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS , cilt.79, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

16. Journey of MS Patients in Turkey; a questionnaire based survey - Burden of MS

Demir S., TÜTÜNCÜ M., Gunduz T., Olmez C., Igde F., Mavi K., et al.

MULTIPLE SCLEROSIS JOURNAL , ss.767-768, 2023 (SCI-Expanded, Scopus)

17. Journey of MS Patients in Turkey; a questionnaire based survey - injection use satisfaction

Demir S., TÜTÜNCÜ M., Gunduz T., Igde F., Olmez C., Mavi K., et al.

MULTIPLE SCLEROSIS JOURNAL , ss.774, 2023 (SCI-Expanded, Scopus)

18. Treatment Adherence in a Large Cohort of Turkish Multiple Sclerosis Population

Seferoglu M., Cinar B. P., Tekan Ü. Y., Avsar F., Yigit P., Sivaci A. O., et al.

MULTIPLE SCLEROSIS JOURNAL , ss.770-771, 2023 (SCI-Expanded, Scopus)

19. Comparison of multiple sclerosis patients with or without rebound activity after fingolimod cessation: Five-year clinical outcomes

Gulec B., Everest E., Gorkey O. D., Koc M., Tutuncu M., Saip S., et al.

EUROPEAN JOURNAL OF NEUROLOGY , cilt.30, sa.9, ss.2745-2751, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

20. The radiologically isolated syndrome: revised diagnostic criteria

Lebrun-Frénay C., Okuda D. T., SİVA A., Landes-Chateau C., Azevedo C. J., Mondot L., et al.

BRAIN , cilt.146, sa.8, ss.3431-3443, 2023 (SCI-Expanded, Scopus)

21. Impact of COVID-19 vaccination or infection on disease activity in a radiologically isolated syndrome cohort: The VaxiRIS study

Cohen M., Thomel-Rocchi O., SİVA A., Okuda D. T., Karabudak R., EFENDİ H., et al.

MULTIPLE SCLEROSIS JOURNAL , cilt.29, sa.9, ss.1099-1106, 2023 (SCI-Expanded, Scopus)

22. Sars-CoV2 infection in pregnant women with multiple sclerosis

Aprea M. G., Schiavetti I., Portaccio E., Ballerini C., Battaglia M. A., Bergamaschi R., et al.

MULTIPLE SCLEROSIS JOURNAL , cilt.29, sa.9, ss.1090-1098, 2023 (SCI-Expanded, Scopus)

23. Parainfectious autoimmune encephalitis related to SARS-CoV-2 infection, presented with catatonia

AKTAN SÜZGÜN M., KOÇHAN KIZILKILIÇ E., Bostan B. U., TÜTÜNCÜ M., KIZILTAN G.

INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE , cilt.58, sa.4, ss.403-410, 2023 (SCI-Expanded, SSCI, Scopus) Sürdürülebilir Kalkınma

24. Prospective outcome analysis of multiple sclerosis cases reveals candidate prognostic markers

Everest E., Uygunoglu U., Tutuncu M., Bulbul A., ONAT U. İ., Unal M., et al.

EUROPEAN JOURNAL OF NEUROLOGY , ss.731, 2023 (SCI-Expanded, Scopus)

25. Journey of MS Patients in Turkey; a questionnaire based survey- Nurse Support Evaluation

Demir S., Tutuncu M., Gunduz T., Mavi K., Olmez C., Igde F., et al.

EUROPEAN JOURNAL OF NEUROLOGY , ss.428-429, 2023 (SCI-Expanded, Scopus)

26. Prospective outcome analysis of multiple sclerosis cases reveals candidate prognostic cerebrospinal fluid markers

Everest E., UYGUNOĞLU U., Tutuncu M., Bulbul A., ONAT U. İ., Unal M., et al.

PLOS ONE , cilt.18, sa.6 JUNE, 2023 (SCI-Expanded, Scopus)

27. Journey of MS Patients in Turkey; a questionnaire based survey

Demir S., Tutuncu M., Gunduz T., Olmez C., Mavi K., Igde F., et al.

EUROPEAN JOURNAL OF NEUROLOGY , ss.427-428, 2023 (SCI-Expanded, Scopus)

28. Ataxia in a Movement Disorders Outpatient Clinic: a Single-Center Experience in Turkey

GÜNDÜZ A., AKTAN SÜZGÜN M., TÜTÜNCÜ M., APAYDIN H., KIZILTAN G.

CEREBELLUM , cilt.22, sa.2, ss.183-191, 2023 (SCI-Expanded, Scopus)

29. Ocrelizumab in pediatric multiple sclerosis

Amirov C. B., Saltik S., Yalcinkaya C., Tutuncu M., Saip S., SİVA A., et al.

EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY , cilt.43, ss.1-5, 2023 (SCI-Expanded, Scopus)

30. Analysis of determinants of treatment change in adult paediatric-onset MS patients

Gulec Z. E., Uygunoglu U., Tutuncu M., Saip S., SİVA A., Yalcinkaya C.

MULTIPLE SCLEROSIS AND RELATED DISORDERS , cilt.69, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

31. The Effect of Smoking on Inactivated and mRNA Vaccine Responses Applied to Prevent COVİD-19 in Multiple Sclerosis

Şen S., Arslan G., Tütüncü M., Demir S., Dinç Ö., GÜNDÜZ T., et al.

Noropsikiyatri Arsivi , cilt.60, sa.3, ss.252-256, 2023 (SCI-Expanded, Scopus, TRDizin)

32. Disease Characteristics of Seropositive Neuromyelitis Optica Spectrum Disorder in a Turkish Cohort

Cam S., Gulec B., TÜTÜNCÜ M., SAİP S., Siva A., UYGUNOĞLU U.

NEUROLOGY , sa.23, 2022 (SCI-Expanded, Scopus)

33. Investigating the role of common and rare variants in multiplex multiple sclerosis families reveals an increased burden of common risk variation

Everest E., Ahangari M., UYGUNOĞLU U., TÜTÜNCÜ M., Bulbul A., SAİP S., et al.

SCIENTIFIC REPORTS , cilt.12, sa.1, 2022 (SCI-Expanded, Scopus)

34. Myoclonus and tremor in chronic inflammatory demyelinating polyneuropathy: a multichannel electromyography analysis

ÇETİNKAYA TEZER D., TÜTÜNCÜ M., AKALIN M. A., UZUN ADATEPE N., SAVRUN F., KIZILTAN M., et al.

ACTA NEUROLOGICA BELGICA , cilt.122, sa.5, ss.1289-1296, 2022 (SCI-Expanded, Scopus)

35. The Socioeconomic and Psychological Impact of the COVID-19 Pandemic on People with Multiple Sclerosis in Turkey

Gunduz T., Uzunkopru C., Demir S., TÜTÜNCÜ M., Seferoglu M., GÜMÜŞ H., et al.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.59, sa.3, ss.226-231, 2022 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

36. Rituximab-induced leukocytoclastic vasculitis

Tezer D. C., Dogan I. G., Arican C. D., Demir S., TÜTÜNCÜ M.

NEUROLOGICAL SCIENCES AND NEUROPHYSIOLOGY , cilt.39, sa.3, ss.161-163, 2022 (SCI-Expanded, Scopus, TRDizin)

37. Prevalence of clinical manifestations and neuroimaging features in cerebral small vessel disease

GEZ S., İNCE F. B., TÜTÜNCÜ M., KIZILTAN G., BAKAR M. T., TANRIVERDİ U., et al.

CLINICAL NEUROLOGY AND NEUROSURGERY , cilt.217, 2022 (SCI-Expanded, Scopus)

38. Determinants of Disability in Progressive Onset Multiple Sclerosis

TÜTÜNCÜ M., Tutuncu M., SAİP S., SİVA A.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.59, sa.1, ss.10-13, 2022 (SCI-Expanded, Scopus, TRDizin)

39. The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: A milder course?

Sen S., Tuncer A., ÖZAKBAŞ S., Uzunkopru C., Baba C., Demir S., et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS , cilt.58, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

40. Tremor and Myoclonus is Common in Immune-mediated and Hereditary Polyneuropathies & nbsp;

ÇETİNKAYA TEZER D., Gunduez A., TÜTÜNCÜ M., AKALIN M. A., UZUN ADATEPE N., SAVRUN F., et al.

NEUROLOGICAL SCIENCES AND NEUROPHYSIOLOGY , cilt.39, sa.1, ss.14-20, 2022 (SCI-Expanded, Scopus, TRDizin)

41. Neuropathic Pain Frequency in Neurology Outpatients: A Multicenter Study

Bekircan-Kurt C. E., Inan B., Bulut O., Sengun I., KARLI H. N., Gunes N., et al.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.58, sa.4, ss.257-260, 2021 (SCI-Expanded, Scopus, TRDizin)

42. A novel diagnostic method for myasthenia gravis.

KOÇAK G. S., TÜTÜNCÜ M., UZUN ADATEPE N., Yerlikaya B. D., Kara E., ATAŞ A., et al.

Muscle & nerve , cilt.64, sa.3, ss.328-335, 2021 (SCI-Expanded, Scopus)

43. Investigation of multiple sclerosis-related pathways through the integration of genomic and proteomic data

Everest E., Ulgen E., UYGUNOĞLU U., TÜTÜNCÜ M., SAİP S., SEZERMAN O. U., et al.

PEERJ , cilt.9, 2021 (SCI-Expanded, Scopus)

44. A comprehensive assessment of patient experience and disease-related awareness in multiple sclerosis: A questionnaire-based nation-wide survey in Turkey.

Demir S., Tutuncu M., Uzunkopru C., Gumus H., Sen S., Gunduz T., et al.

Multiple sclerosis and related disorders , cilt.52, ss.103005, 2021 (SCI-Expanded, Scopus)

45. The efficacy of rituximab in patients with neuromyelitis optica spectrum disorder: A real-world study from Turkey.

Uzunkopru C., Tutuncu M., GÜNDÜZ T., Gumus H., Sen S., Demir S., et al.

International journal of clinical practice , cilt.75, sa.7, 2021 (SCI-Expanded, Scopus)

46. The outcome of a national MS-Covid-19 study: What the Turkish MS cohort reveals?

Sen S., Karabudak R., Schiavetti I., Demir S., Ozakbas S., Tutuncu M., et al.

Multiple sclerosis and related disorders , cilt.52, ss.102968, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

47. Frequency and pattern of cognitive dysfunction in Neuro-Behcet's disease: a retrospective study

Tutuncu M., Uygunoglu U., Bingol A., Saip S., Siva A.

CUKUROVA MEDICAL JOURNAL , sa.2, ss.621-626, 2021 (ESCI, TRDizin)

48. Estimation of Parkinson's disease severity using speech features and extreme gradient boosting

Tunc H. C., ŞAKAR C. O., APAYDIN H., SERBES G., GÜNDÜZ A., TÜTÜNCÜ M., et al.

MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING , cilt.58, sa.11, ss.2757-2773, 2020 (SCI-Expanded, Scopus)

49. Cutaneous silent period in patients with spinal muscular atrophy type 2 and type 3.

Gunduz A., Kofler M., Aktan S., Tutuncu M., Karaali-Savrun F., Uzun N., et al.

Neurophysiologie clinique = Clinical neurophysiology , cilt.50, sa.5, ss.353-359, 2020 (SCI-Expanded, Scopus)

50. Brain MRI findings in patients in the intensive care unit with COVID-19 infection

Kandemirli S. G., Dogan L., SARIKAYA Z. T., KARA S., Akinci C., KAYA D., et al.

Radiology , cilt.297, sa.1, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

51. The efficacy of anti- IL-1 treatment in three patients with coexisting familial Mediterranean fever and multiple sclerosis

Ozdogan H., Ugurlu S., Uygunoglu U., Tutuncu M., Gul A., Akman G., et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS , cilt.45, 2020 (SCI-Expanded, Scopus)

52. The effect of vitamin D on restless legs syndrome: prospective self-controlled case study

Tutuncu M., Tutuncu M.

SLEEP AND BREATHING , cilt.24, sa.3, ss.1101-1106, 2020 (SCI-Expanded, Scopus)

53. Co-existence of multiple sclerosis and anti-NMDA receptor encephalitis: A case report and review of literature

Gulec B., Kurucu H., Bozbay S., Dikmen Y., Sayman H. B., TÜZÜN E., et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS , cilt.42, 2020 (SCI-Expanded, Scopus)

54. CD4(+) T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS

Cebi M., Durmus H., Aysal F., Ozkan B., Gul G. E., Cakar A., et al.

FRONTIERS IN IMMUNOLOGY , cilt.11, 2020 (SCI-Expanded, Scopus)

55. Brainstem reflexes in neuro-Behcet disease

Akinci Y., ASAN F., Sohtaoglu M., TÜTÜNCÜ M., UYGUNOĞLU U., SAİP S., et al.

NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY , cilt.49, sa.5, ss.381-384, 2019 (SCI-Expanded, Scopus)

56. Apparent diffusion coefficient characteristics of parenchymal neuro-Behcet's disease

Alis D., Alis C., Tutuncu M., Kocer N., Islak C., Kizilkilic O.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.22, sa.8, ss.1452-1458, 2019 (SCI-Expanded, Scopus)

57. A comparative analysis of speech signal processing algorithms for Parkinson's disease classification and the use of the tunable Q-factor wavelet transform

Sakar C. O., Serbes G., Gunduz A., Tunc H. C., Nızam H., Sakar B. E., et al.

APPLIED SOFT COMPUTING , cilt.74, ss.255-263, 2019 (SCI-Expanded, Scopus)

58. Relationship Between Sleep-related Violence and NREM Parasomnia: A Case Report

Tutuncu M., Senel G., Zeydan B., Karadeniz D., Apaydin H.

JOURNAL OF TURKISH SLEEP MEDICINE-TURK UYKU TBB DERGISI , cilt.5, sa.2, ss.46-49, 2018 (ESCI, TRDizin)

59. Myoclonus in the elderly: A retrospective analysis of clinical and electrophysiological characteristics of patients referred to an electrophysiology laboratory.

Kiziltan M. E., Gunduz A., Tutuncu M., Ertan S., Apaydin H., Kiziltan G.

Parkinsonism & related disorders , cilt.49, ss.22-27, 2018 (SCI-Expanded, Scopus)

60. Posterior auricular muscle response: Observations in brainstem lesions Beyin sapı lezyonlarında posterior auriküler kas yanıtının araştırılması

Abanoz Y. G., Abanoz Y., Akinci Y., Gunduz A., Bulus E., Tutuncu M., et al.

Turk Noroloji Dergisi , cilt.24, sa.3, ss.243-247, 2018 (Scopus, TRDizin)

61. Comparative study of video-assisted thoracoscopic surgery versus open thymectomy for thymoma and myasthenia gravis

Ersen E., Kilic B., Kara H. V., Iscan M., Sarbay I., DEMİRKAYA A., et al.

VIDEOSURGERY AND OTHER MINIINVASIVE TECHNIQUES , cilt.13, sa.3, ss.376-382, 2018 (SCI-Expanded, Scopus)

62. Factors Predictive of Severe Multiple Sclerosis Disease Reactivation After Fingolimod Cessation

Uygunoglu U., Tutuncu M., Altintas A., Saip S., Siva A.

NEUROLOGIST , cilt.23, sa.1, ss.12-16, 2018 (SCI-Expanded, Scopus)

63. Electrophysiological Investigations in Orthostatic Myoclonus: Preliminary Findings.

Gunduz A., Tutuncu M., Zeydan B., Apaydin H., Kiziltan G., Ertan S., et al.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques , cilt.45, sa.1, ss.100-103, 2018 (SCI-Expanded, Scopus)

64. Assessment of the common carotid artery wall stiffness by Shear Wave Elastography in Behcet's disease

Alis D., Durmaz E. S. M., Alis C., Tutuncu M., Saip S., Kocer N., et al.

MEDICAL ULTRASONOGRAPHY , cilt.20, sa.4, ss.446-452, 2018 (SCI-Expanded, Scopus)

65. Integrated Genomic and Proteomic Analyses of Multiple Sclerosis

Everest E., Uygunoglu U., Tutuncu M., SAİP S., SEZERMAN O. U., Siva A., et al.

NEUROLOGY , cilt.88, 2017 (SCI-Expanded, Scopus)

66. The Effects of Dalfampridine on Hereditary Spastic Paraparesis

Uygunoglu U., GUNDUZ A., TUTUNCU M., AKALIN M. A., SAIP S., SIVA A.

EUROPEAN NEUROLOGY , cilt.76, ss.152-153, 2016 (SCI-Expanded, Scopus)

67. Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis

Novotna M., Soldan M. M. P., Abou Zeid N., Kale N., Tutuncu M., Crusan D. J., et al.

NEUROLOGY , cilt.85, sa.8, ss.722-729, 2015 (SCI-Expanded, Scopus)

68. CSF Proteomics Identifies Specific and Shared Pathways for Multiple Sclerosis Clinical Subtypes

Avsar T., Durasi I. M., Uygunoglu U., Tutuncu M., Demirci N. O., Saip S., et al.

PLOS ONE , cilt.10, sa.5, 2015 (SCI-Expanded, Scopus)

69. Auditory Evoked Blink Reflex in Peripheral Facial Paresis

Ayta S., Sohtaoglu M., Uluduz D., Uygunoglu U., Tutuncu M., Akalin M. A., et al.

JOURNAL OF CLINICAL NEUROPHYSIOLOGY , cilt.32, sa.1, ss.34-38, 2015 (SCI-Expanded, Scopus)

70. Relapses and disability accumulation in progressive multiple sclerosis

Soldan M. M. P., Novotna M., Abou Zeid N., Kale N., Tutuncu M., Crusan D. J., et al.

NEUROLOGY , cilt.84, sa.1, ss.81-88, 2015 (SCI-Expanded, Scopus)

71. Radiologically Isolated Syndrome: 5-Year Risk for an Initial Clinical Event

Okuda D. T., Siva A., Kantarci O., Inglese M., Katz I., Tutuncu M., et al.

PLOS ONE , cilt.9, sa.3, 2014 (SCI-Expanded, Scopus)

72. Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis

Tutuncu M., Tang J., Abou Zeid N., Kale N., Crusan D. J., Atkinson E. J., et al.

MULTIPLE SCLEROSIS JOURNAL , cilt.19, sa.2, ss.188-198, 2013 (SCI-Expanded, Scopus)

73. Protein biomarkers for multiple sclerosis: Semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis

Avsar T., Korkmaz D., Tutuncu M., Demirci N. O., Saip S., Kamasak M., et al.

Multiple Sclerosis Journal , cilt.18, sa.8, ss.1081-1091, 2012 (SCI-Expanded, Scopus)

74. A patient with established primary progressive multiple sclerosis transitions to 'secondary' relapsing-remitting disease course following a fulminant demyelinating episode

Tutuncu M., Demirci N. O., Ozer F., Saip S., Kantarci O. H., Siva A.

MULTIPLE SCLEROSIS JOURNAL , cilt.17, sa.10, ss.1262-1264, 2011 (SCI-Expanded, Scopus)

75. Does smoking really impact progression in multiple sclerosis?

Jansons L., Tutuncu M., Tang J., Kale N., Zeid N., Crusan D., et al.

MULTIPLE SCLEROSIS JOURNAL , cilt.17, 2011 (SCI-Expanded, Scopus)

76. Long-term effects of cognitive rehabilitation in multiple sclerosis: six months follow-up

Topcular B., Bingol A., Yildiz S., Tutuncu M., Demirci O., Saip S., et al.

MULTIPLE SCLEROSIS JOURNAL , cilt.17, 2011 (SCI-Expanded, Scopus)

77. Validation of the Multiple Sclerosis Neuropsychological Screening Questionnaire in Turkish

Bingol A., Topcular B., Yildiz S., Tutuncu M., Demirci O., Saip S., et al.

MULTIPLE SCLEROSIS JOURNAL , cilt.17, 2011 (SCI-Expanded, Scopus)

78. Evaluation of Parenchymal Neuro-Behcet Disease by Using Susceptibility-Weighted Imaging

Albayram S., Saip S., Hasiloglu Z. I., Teke M., Ceyhan E., Tutuncu M., et al.

AMERICAN JOURNAL OF NEURORADIOLOGY , cilt.32, sa.6, ss.1050-1055, 2011 (SCI-Expanded, Scopus)

79. Postprandial, but not fasting insulin secretion is augmented in migraine. are migraineurs at high risk for future insulin resistance syndrome?

Siva Z. O., Uluduz D. U., BALCI H. İ., Tutuncu M., ÇELİK A., Avci F., et al.

JOURNAL OF HEADACHE AND PAIN , cilt.11, 2010 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 6